glycyl-arginyl-glycyl-aspartyl-serine and Carcinoma, Hepatocellular

glycyl-arginyl-glycyl-aspartyl-serine has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, TF; Lin, CH; Peng, HC; Sheu, JR	1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and Carcinoma, Hepatocellular

Article	Year
Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1996, Volume: 213, Issue:1 Topics: Antibodies, Monoclonal; Carcinoma, Hepatocellular; Cell Adhesion; Extracellular Matrix; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Antibody Technique, Indirect; Humans; Integrins; Liver Neoplasms; Oligopeptides; Peptides; Platelet Aggregation Inhibitors; Tumor Cells, Cultured	1996

Article

Year

Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1996, Volume: 213, Issue:1

Topics: Antibodies, Monoclonal; Carcinoma, Hepatocellular; Cell Adhesion; Extracellular Matrix; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Antibody Technique, Indirect; Humans; Integrins; Liver Neoplasms; Oligopeptides; Peptides; Platelet Aggregation Inhibitors; Tumor Cells, Cultured

1996